Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 3,691,518 CBIO shares, 9.8% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:09:10 UTC.

Accession
0000921895-26-003172
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
3,691,518
Percent of class
9.8%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN01,937,71201,937,7121,937,7125.2%
BVF I GP LLCOO01,937,71201,937,7121,937,7125.2%
BIOTECHNOLOGY VALUE FUND II LPPN01,453,03701,453,0371,453,0373.9%
BVF II GP LLCOO01,453,03701,453,0371,453,0373.9%
Biotechnology Value Trading Fund OS LPPN0244,1870244,187244,1870.7%
BVF Partners OS Ltd.CO0244,1870244,187244,1870.7%
BVF GP HOLDINGS LLCOO03,390,74903,390,7493,390,7499%
BVF PARTNERS L P/ILIA,PN03,691,51803,691,5183,691,5189.8%
BVF INC/ILCO03,691,51803,691,5183,691,5189.8%
LAMPERT MARK NIN03,691,51803,691,5183,691,5189.8%